Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6759-6766

  Bertran, Joan ^a   Miller, Jeffery L ^b   Yang, Yanping ^a   Fenimore Justman, Angela ^a   Rueda, Felix ^a,e   Vanin, Elio F ^a,c   Nienhuis, Arthur W ^a,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; MEMBRANE RECEPTOR;

ADENO ASSOCIATED VIRUS; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL SELECTION; CHROMOSOME 19; ECOTROPIC VIRUS; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0029817995     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6759-6766.1996     Document Type: Article

References (67)

1. Albritton, L. M., J. W. Kim, L. Tseng, and J. M. Cunningham. 1993. Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J. Virol. 67:2091-2096.
2. Albritton, L. M., L. Tseng, D, Scadden, and J. M. Cunningham. 1989. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57:659-666.
3. Alexander, I. E., D. W. Russell, and A. D. Miller. 1994. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68:8282-8287.
4. Berns, K. I., and R. A. Bohenzky. 1987. Adeno-associated viruses: an update. Adv. Virus Res. 32:243-306.
5. -SC1D: initial trial results after 4 years. Science 270:475-480.
6. - immunodeficient patients. Science 270:470-475.
7. Brenner, M. K., D. R. Rill, H. E. Heslop, C. M. Rooney, W. M. Roberts, C. Li, T. Nilson, and R. A. Krance. 1994. Gene marking after hone marrow transplantation. Eur. J. Cancer 30A:1171-1176.
8. Brenner, M. K., D. R. Rill, R. C. Moen, R. A. Krance, J. Mirro, Jr., W. F. Anderson, and J. N. Ihle. 1993. Gene-marking to trace origin of relapse after autologous hone-marrow transplantation. Lancet 341:85-86.
9. Chiorini, J. A., C. M. Wendtner, E. Urcelay, B. Safer, M. Hallek, and R. M. Kotin. 1995. High-efficiency transfer of the T-cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6:1531-1541.
10. Clark, K. R., F. Voulgaropoulou, D. M. Fraley, and P. R. Johnson. 1995. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6:1329-1341.
11. Closs, E. I., I. H. M. B. Rinkes, A. Bader, M. L. Yarmush, and J. M. Cunningham. 1993. Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes. J. Virol. 67:2097-2102.
12. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
13. Dilloo, D. Unpublished data.
14. Doane, F. W., and N. Anderson. 1987. Methods for preparing specimens for electron microscopy, p. 14-31. In Electron microscopy in diagnostic virology: a practical guide and atlas. Cambridge University Press, New York.
15. Dunbar, C. E., and R. V. Emmons. 1994. Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Stem Cells 12:563-576.
16. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
17. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
18. Fisher, K. J., G.-P. Gao, M. D. Weitzman, R. DeMatteo, J. F. Burda, and J. M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
19. Flotte, T. R., S. A. Afione, C. Conrad, S. A. McGrath, R. Solow, H. Oka, P. L. Zeiltin, W. B. Guggino, and B. J. Carter. 1993. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90:10613-10617.
20. Flotte, T. R., S. A. Afione, and P. L. Zeitlin. 1994. Adeno-associated virus vector gene expression occurs in non-dividing cells in the absence of vector DNA integration. Am. J. Respir. Cell. Mol. Biol. 11:517-521.
21. Flotte, T. R., and B. J. Carter. 1995. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:357-362.
22. Giraud, C., E. Winocour, and K. I. Berns. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69:6917-6924.
23. Goodman, S., X. Xiao, R. E. Donahue, A. Moulton, J. Miller, C. Walsh, N. S. Young, R. J. Samulski, and A. W. Nienhuis. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500.
24. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
25. Halbert, C. L., I. E. Alexander, G. M. Wolgamot, and A. D. Miller. 1995. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69:1473-1479.
26. Hargrove, P., and A. W. Nienhuis. Unpublished data.
27. Hermonat, P. L., and N. Muzyczka. 1984. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 81:6466-6470.
28. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
29. Johnson, D., A. Lanahan, C. R. Buck, A. Sehgal, C. Morgan, E. Mercer, M. Bothwell, and M. Chao. 1986. Expression and structure of the human NGF receptor. Cell 47:545-554.
30. Kadan, M. J., S. Sturm, F. Andersen, and M. A. Eglitis. 1992. Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66:2281-2287.
31. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
32. Kohn, D. B., K. I. Weinberg, J. A. Nolta, L. N. Heiss, C. Lenarsky, G. M. Crooks, M. E. Hanley, G. Annett, J. S. Brooks, A. El-Khoureiy, K. Lawrence, S. Wells, R. C. Moen, J. Bastain, D. E. Williams-Herman, M. Elder, D. Wara, T. Bowen, M. S. Hershfield, C. A. Mullen, R. M. Blaese, and R. Parkman. 1995. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1:1017-1023.
33. Kotin, R. M. 1994. Prospects for use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5:793-801.
34. Kotin, R. M., J. C. Menninger, D. C. Ward, and K. I. Berns. 1991. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831-834.
35. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. Zhu, L. Hunier, C. A. Laughlin, S. McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
36. Lebkowski, J. S., M. N. McNally, T. B. Okarma, and L. B. Lerch. 1988. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol. 8:3988-3996.
37. Lieber, A., M.-J. T. F. D. V. Peeters, and M. A. Kay. 1995. Adenovirus-mediated transfer of the amphotropic retrovirus receptor cDNA increases retroviral transduction in cultured cells. Hum. Gene Ther. 6:5-11.
38. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
39. McLaughlin, S. K., P. Collis, P. L. Hermonat, and N. Muzyczka. 1988. Adeno-associated virus as general transduction vectors: analysis of proviral structures. J. Virol. 62:1963-1973.
40. Miller, A. D., D. G. Miller, J. V. Garcia, and C. M. Lynch. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217: 581-599.
41. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
42. Miller, J. L. Unpublished data.
43. Miller, J. L., R. E. Donahue, S. E. Sellers, R. J. Samulski, N. S. Young, and A. W. Nienhuis. 1994. Recombinant adeno-associated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91:10183-10187.
44. Mizukami, H., S. Muramatsu, N. S. Young, and K. E. Brown. 1995. Adeno-associated virus type 2 binds to 150kd cell membrane glycoprotein. Blood 86(Suppl. 1):240a.
45. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
46. Muzyckza, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
47. Nienhuis, A. W., C. E. Walsh, and J. Liu. 1993. Viruses as therapeutic gene transfer vectors, p. 353-414. In N. S. Young (ed.), Viruses in bone marrow. Marcel Dekker, Inc., New York.
48. Orlic, D., A. P. Cline, N. E. Seidel, L. J. Girard, C. T. Jordan, and D. M. Bodine. 1995. The relative level of expression of retrovirus receptor mRNAs in mouse and human primate hematopoietic stem cells predicts the efficiency of gene transfer. Blood 86(Suppl. 1):628a.
49. Podsakoff, G., K. K. Wong, Jr., and S. Chatterjee. 1994. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol. 68:5656-5666.
50. Rill, D. R., V. M. Santana, W. M. Roberts, T. Nilson, L. C. Bowman, R. A. Krance, H. E. Heslop, R. C. Moen, J. N. Ilhe, and M. K. Brenner. 1994. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383.
51. Russell, D. W., I. E. Alexander, and A. D. Miller. 1995. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92:5719-5723.
52. Russell, D. W., A. D. Miller, and I. E. Alexander. 1994. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915-8919.
53. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989, Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor. N.Y.
54. Samulski, R. J., K. I. Berns, M. Tan, and N. Muzyczka. 1982. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 79:2077-2081.
55. Samulski, R. J., L. S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3096-3101.
56. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
57. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
58. Spencer, H. T., S. E. H., Sleep, J. E. Regh, R. Blakely, and B. P. Sorrentino. 1996. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87:2579-2587.
59. Tamayose, K., Y. Hirai, and T. Shimada. 1996. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7:507-513.
60. Tratschin, J.-D., I. L. Miller, M. G. Smith, and B. J. Carter. 1985. Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol. Cell. Biol. 5:3251-3260.
61. Urcelay E., P. Ward, S. M. Wiener, B. Safer, and R. M. Kotin. 1995 Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69:2038-2046.
62. Walsh, C. E., J. M. Liu, X. Xiao, N. S. Young, A. W. Nienhuis, and R. J. Samulski. 1992. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 89:7257-7261.
63. Walsh, C. E., A. W. Nienhuis, R. J. Samulski, M. G. Brown, J. L. Miller, N. S. Young, and J. M. Liu. 1994. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J. Clin. Invest. 94:1440-1448.
64. Weitzman, M. D., S. R. M. Kyöstiö, R. M. Kotin, and R. A. Owens. 1994. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 91:5808-5812.
65. Yang, Y., A. N. Frederick, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adeno-viruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
66. Yang, Y., E. F. Vanin, M. A. Whitt, M. Fornerod, R. Zwart, R. D. Schneiderman, G. Grosveld, and A. W. Nienhuis. 1995. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum. Gene Ther. 6:1203-1213.
67. Zhou, S. Z., S. Cooper, L. Y. Kang, L. Ruggieri, S. Heimfeld, A. Srivastava, and H. E. Broxmeyer. 1994. Adeno-associated virus 2-mediated high efficiency gene transfer into inmature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J. Exp. Med. 179:1867-1875.